Rayna S. Guo

Rayna S. Guo

Associate

Mergers & Acquisitions

Rayna Guo is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on mergers and acquisitions. She advises both public and private clients in mergers, tender offers, asset acquisitions, stock purchases, and other strategic corporate transactions.

Prior to joining the firm, Rayna was an associate in the New York office of Sullivan & Cromwell, where she was a member of the financial services group and mergers and acquisitions group.

Experience

Prior to joining the firm, Rayna was an associate in the New York office of Sullivan & Cromwell, where she was a member of the financial services group and mergers and acquisitions group.

Education

J.D., Columbia Law School, 2020
B.A., Economics and Political Science, University of Chicago, 2014

Admissions

State Bar of New York

Credentials

Education

J.D., Columbia Law School, 2020
B.A., Economics and Political Science, University of Chicago, 2014

Admissions

State Bar of New York

Mergers & Acquisitions

Recent Insights

Client Highlights

On April 6, 2026, Neurocrine Biosciences and Soleno Therapeutics announced that Neurocrine has entered into a definitive agreement to acquire Soleno for $53.00 per share in cash, representing a total transaction equity value of $2.9 billion. Wilson Sonsini Goodrich & Rosati is advising Soleno on the transaction.

Learn More

Client Highlights

On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.

Learn More